Treatment with oxaliplatin and an EGFR-inhibitor

Details for Australian Patent Application No. 2005249200 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Higgins, Brian; Kolinsky, Kenneth; Chen, Jianping

Agent Davies Collison Cave

Pub. Number AU-A-2005249200

PCT Pub. Number WO2005/117915

Priority 60/576,435 03.06.04 US

Filing date 25 May 2005

Wipo publication date 15 December 2005

International Classifications

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 38/50 (2006.01) Medicinal preparations containing peptides

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117915 Priority application(s): WO2005/117915

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249201-Treatment with irinotecan (CPT-11) and an EGFR-inhibitor

2005249196-Naphthaline derivatives useful as histamine-3-receptor ligands